Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen

Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen

Abstract Background The optimal treatment for polypoidal choroidal vasculopathy (PCV) is still under debate. Little knowledge is known about the treatment effect of “1+pro re nata(PRN)” treatment regimen for PCV. The aim of this study was to compare the outcomes of photodynamic therapy (PDT), intrav...

Full description

Bibliographic Details
Main Authors: Kunbei Lai, Ying Li, Lijun Zhou, Xiaojin Zhong, Chuangxin Huang, Fabao Xu, Lin Lu, Jian Ge, Chenjin Jin
Format: Article
Language:English
Published: BMC 2018-06-01
Series:BMC Ophthalmology
Subjects:
Polypoidal choroidal vasculopathy
Photodynamic therapy
Ranibizumab
Combination therapy
Cost-benefit
Online Access:http://link.springer.com/article/10.1186/s12886-018-0801-7

Internet

http://link.springer.com/article/10.1186/s12886-018-0801-7

Similar Items